Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy Injections in An Office Setting
To access this article, please choose from the options below
PII: S0002-9394(08)00015-9
doi:10.1016/j.ajo.2007.12.036
© 2008 Elsevier Inc. All rights reserved.
